Home/Filings/4/0001213900-25-031196
4//SEC Filing

ELRAY RESOURCES, INC. 4

Accession 0001213900-25-031196

$ELRACIK 0001690080operating

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 6:05 PM ET

Size

7.8 KB

Accession

0001213900-25-031196

Insider Transaction Report

Form 4
Period: 2025-03-27
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2025-03-271,000,0000 total
    From: 2024-12-27Common Stock (1,318,000 underlying)
  • Conversion

    Common Stock

    2025-03-27+1,318,0001,318,000 total
Footnotes (3)
  • [F1]On March 27, 2025, Elray Resources, Inc., converted all 1,000,000 outstanding shares of Series B Convertible Preferred Stock of the Issuer which it then held into 1,318,000 shares of common stock (1.318 shares of common stock for each share of Series B Convertible Preferred Stock converted), in accordance with the terms of such preferred stock and the optional conversion right set forth therein.
  • [F2]Each of the 1,000,000 shares of Series B Convertible Preferred Stock was convertible into 1.318 shares of common stock.
  • [F3]The Series B Convertible Preferred Stock has no expiration date.

Documents

1 file

Issuer

180 Life Sciences Corp.

CIK 0001690080

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001402371

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 6:05 PM ET
Size
7.8 KB